Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU) , today announced the appointment of Brad Saar, former ...

CHARLOTTE, N.C., July 9 USHIFU, LLC, a global leader innon invasive high intensity focused ultrasound (HIFU) technology, is proud toannounce sponsorship of the Sonablate(R) International HIFU Registry ...

CHARLOTTE, NC / ACCESSWIRE / July 6, 2018 / A 5-year multicenter study following focal therapy for prostate cancer, with the Sonablate HIFU technology, has been published and shows it is possible to ...

CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE)-- Sonablate, a global leader in focused ultrasound technologies, today announced key additions to its leadership team as it scales “precision sound ...

SonaCare Medical has reported five-year outcomes from a study of focal therapy using its Sonablate high-intensity focused ultrasound (HIFU) system. The multicentre study included 625 patients with ...

Los Angeles-based miVIP Surgery Centers is the first in Southern California to offer outpatient treatment with Sonablate for prostate cancer. 1. Sonablate is designed to provide high intensity focused ...

CHARLOTTE, NC, UNITED STATES, June 21, 2023/EINPresswire.com/ -- Sonablate Corp., a global leader in minimally invasive focused ultrasound technologies, today ...

CHARLOTTE, N.C., Dec. 2 USHIFU, a worldwide leader in thedevelopment, distribution and use of minimally invasive high intensity focusedultrasound technologies, announced today the establishment of ...

This is a companion article to Ultrasound’s war on prostate cancer, which was published in the July 2011 issue of Test & Measurement World. For companies who make medical devices, the path to FDA ...

The MarketWatch News Department was not involved in the creation of this content. CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Sonablate, a global leader in focused ultrasound technologies, ...

(MENAFN- ein presswire) by introducing sonablate hifu to our range of treatments, we can provide patients with a highly targeted, minimally invasive alternative.” - dr. bertram lewischarlotte, nc, ...